This report provides exclusive insights into the COVID-19 impact on the Infectious Disease Diagnostic Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Infectious Disease Diagnostic Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Infectious Disease Diagnostic Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on infectious disease diagnostic market provides
in-depth analysis of segments and sub-segments in the global as well as
regional infectious disease diagnostic market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
infectious disease diagnostic market over the short term as well as long term.
The report is a comprehensive presentation of trends, forecast and dollar
values of global infectious disease diagnostics market. According to the report,
the global infectious disease diagnostic market is projected to grow at a CAGR of
8.7% over the forecast period of 2019-2025.
Market Insight
Infectious disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized.
Infectious disease is one of the common medical condition that accounts for
millions of deaths each year. The several types of bacteria, viruses, fungi or
parasites are organisms that cause infectious disorders including tuberculosis,
malaria, AIDS, and others. It can be based solely on clinical presentation or
more rigorous diagnostic tests, such as culturing of the infectious agent,
microscopy, biochemical screens, and molecular methods.
Increasing incidences of infectious diseases are the key factor that drives the growth of infectious disease diagnosis market.
Additionally, increasing demand for advanced technologies in the treatment of
infectious disease, and high investment in R&D activities from government
and private organizations are fueling the growth of infectious disease
diagnostic market. Furthermore, the introduction of point of care diagnosis
market to provide high quality, sensitivity, accuracy, and reliability are
contributing to the growth of infectious diseases diagnostics market. However,
lack of awareness of novel diagnostic technologies, the cost associated with
the IDD treatment and stringent government regulatory guidelines are the prime
factors restraining the growth of this growth. Moreover, companies operating in
the market, which is focusing on developing novel diagnostics, as well as
initiatives are taken by the government and private organizations pertaining
to the diagnosis of the infectious diseases among the people provide more
opportunities for the market to grow over the forecast period.
Among the geographies, North America holds the maximum
market share in the infectious disease diagnostic market followed by Europe.
The growing occurrence of infectious diseases and rising the shift towards
decentralized laboratories are the primary factors that drive the growth of
North America infectious diseases market. Addition developed healthcare
infrastructure and ongoing research on Infectious disease diagnostics are
favoring the growth of Infectious disease diagnostics market in the North
America region. Furthermore, Asia Pacific is the fastest growing region in the
Infectious disease diagnostics market majorly owing to the growing awareness
about the Infectious disease and their diagnostics and rising healthcare
expenditure.

Segment Covered
The report on global infectious
disease diagnostic market covers segments such as product, technology,
application, and end users. On the basis of product, the sub-markets include
instruments, reagents, and software & services. On the basis of technology,
the sub-markets include conventional technology, biochemical technology, and
molecular technology. On the basis of application, the sub-markets include
bacterial infection, viral infection, CNS infection, cardiovascular infection,
fungal infection, sexually transmitted disease, and other applications. On the basis of end
users, the sub-markets include hospital and research institutes.
Companies Profiled:
The report provides profiles of
the companies in the market such as Beckman Coulter, Inc., Chembio Diagnostic
Systems, Inc., Orasure Technologies, Bio-Rad Laboratories, Inc., BioMérieux, Hologic, Inc., Danaher Corporation, Quidel Corporation, Trinity Biotech plc, Meridian Bioscience
Inc., and other companies.
Report Highlights:
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of infectious disease diagnostic market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.